# Alignment Healthcare Inc. (ALHC) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Providers & Services. Price $13.54, market value $2.8 billion.

## Valuation
- **P/E (trailing): 71.3×**. Alignment Healthcare Inc. trades at 71.3× trailing earnings. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 18.0×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.18**. A PEG of 0.18 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.6×**. Each dollar of revenue is priced at 0.6×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 10.6×**. The shares trade at 10.6× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **EV / EBITDA: 29.5×**. Enterprise value is 29.5× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 6.3%** (5-yr avg -1.7%). Free cash flow equals 6.3% of the market value, above its five-year average of -1.7%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 1.4%**. The inverse of the P/E: 1.4% of the price is earned each year.

## Profitability
- **Operating margin: 1.2%**. 1.2% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: -0.0%**. The company reported a net loss over the last twelve months.
- **Return on equity: -0.4%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -59.2%**. Return on all capital, debt included, is -59.2%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 3.8%**. Each dollar of assets produces 3.8% of profit.

## Growth
- **Revenue growth (1 yr): 46.1%** (3-yr 40.2%/yr, 5-yr 32.8%/yr). Revenue grew 46.1% over the last year, against 32.8% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 100.0%**. Earnings per share rose 100.0%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 1.80**. Debt is 1.80 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: net cash**. Alignment Healthcare Inc. holds more cash than debt.
- **Altman Z-score: 5.89**. A Z-score of 5.89 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Alignment Healthcare Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (13 analysts). 13 analysts cover Alignment Healthcare Inc.; the consensus is strong_buy, with an average price target of $24.08 (+78% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -16.9%** (YTD -31.4%, 3-mo -11.9%). The shares are down 16.9% over twelve months including dividends.
- **From 52-week high: -46.1%** (6.6% above the low). Trading 46% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 39**. An RSI of 39 is neutral.
- **Beta (1 yr): 0.33** (volatility 62%). Beta of 0.33 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ALHC · Page: https://foliofundamentals.com/stocks/alhc

Not investment advice.